Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression

The aim of this study is to compare the therapeutic effect between endostar plus adjuvant chemotherapy and adjuvant chemotherapy alone in the patients with completely resected non-small cell lung cancer (NSCLC) at stage IB to IIIA. This is an open, multicenter, randomized (1:1) study with 250 NSCLC...

Full description

Bibliographic Details

Published in:	Oncotarget Vol. 8; no. 45; pp. 79703 - 79711
Main Authors:	Chen, Zhiwei, Luo, Qingquan, Zhou, Zhen, Jian, Hong, Lu, Shun, Liao, Meilin
Format:	Journal Article
Language:	English
Published:	United States Impact Journals LLC 03-10-2017
Subjects:	Clinical Research Paper non-small cell lung cancer cisplatin endostar VEGF
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!